Abstract
Peptidomimetic inhibitors based on the C-terminal sequence of herpes simplex virus (HSV) ribonucleotide reductase (RR) small subunit (R2) also inhibit varicella zoster virus (VZV) RR. There is generally good correlation between the potencies against both HSV and VZV RR. There are, however, two important differences. A urea moiety at the N-terminus improves potency against HSV RR but offers no advantages against VZV RR. γ-Methylleucine at the C-terminus is also beneficial for HSV RR but decreases potency considerably for VZV RR.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
